View drug registration information details.
Items | Registration information |
ID | 1702 |
No | 1702 |
Brand Name | LUCICAPIVA |
Ingredients | CAPAVASERTIB 200 MG |
Dosage Form | TABLET |
Primary Packaging | BOTTLE |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 64'S/BOTTLE |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF ADULT PATIENTS WITH HORMONE RECEPTOR POSITIVE, HYMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE, LOCALLY ADVANCED OR METASTATIC BREAST CANCER WITH ONE OR MORE PIK3CA/AKT1/PTEN ALTERATION FOLLOWING PROGRESSION ON AT LEAST ONE ENDOCRINE BASED REGIMENT ON THE METASTATIC SETTING OR RECURRENT ON OR WITHIN 12 MONTHS OF CONPLETING ADJUVANT THERAPY |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | YELLOW, BICONVEX FILM COATED TABLET, WITH LETTER LUCIUS ON ONE SIDE AND PLAIN ON THE OTHER SIDE |
Note | |
License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
Country | LAOS |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 08 L 1160/24 |
FDD Registration Date | 21-AUG-2024 |
Expiry Date | 20-AUG-2027 |
Back to drug list
|